Ads
related to: ny times review of books
Search results
The Case Against Trump is Strong and Has Been Proven Beyond a Reasonable Doubt: Former NY Prosecutor
Los Angeles Magazine· 3 days agoIt's in the hands of the jury, but will the jury convict a former President? Former Manhattan DA prosecutor Karen Friedman Agnifilo weighs in
Caleb Carr, military historian and author of bestselling novel 'The Alienist,' dies at 68
McComb Enterprise-Journal· 7 days agoThis undated self portrait made available by Little Brown publisher, shows author Caleb Carr and his...
E. Jean Carroll’s attorney hints at going after Trump again after a Memorial Day shoutout
BizPac Review· 2 days agoDefamation redux could be inbound for the former president as E. Jean Carroll’s attorney hinted at more lawfare after a Memorial Day shoutout included a reference to “Human Scum.” With clients ...
12 ways Apple Maps can help you plan a successful summer vacation
ZDNet· 2 days agoApple Maps will provide turn-by-turn directions and highlight the best hotels, restaurants, and...
Chris Hemsworth’s touching shoutout to his supportive wife treads into cancel culture territory
BizPac Review· 2 days agoThursday was Thor’s-day in Los Angeles as blockbuster actor Chris Hemsworth was honored with his own star on the Hollywood Walk of Fame. Joined by co-stars, friends, and family, the Australian ...
J6 Capitol police to stump for Biden in battleground states
BizPac Review· 3 days agoIn selling a campaign of fear, President Joe Biden’s team unveiled how they were taking Jan. 6 on a battleground state tour. A public relations nightmare continued to unfold for the incumbent ...
High-dollar donor bait: Bill and Hillary Clinton tapped to headline ‘mega fundraiser’ for Biden
BizPac Review· 4 days agoIf public-private partnerships with corporate stakeholders picking winners and losers aren’t enough to demonstrate where Democratic politicians’ loyalties truly fall, an upcoming swamp shindig ...
Merus Announces Pricing of Upsized Public Offering of Common Shares - Merus (NASDAQ:MRUS)
Benzinga· 1 day agoMerus N.V. MRUS ("Merus", the "Company," "we" and "our"), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced ...
